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Effects of prenatal exposure to glucocorticoids in impulsivity and 
novelty-seeking behavior 
Abstract 
Early life stress (ELS) or elevated levels of glucocorticoids (GCs) may result in persistent 
effects in the central nervous system that can lead to maladaptive behavior in adult life and 
increase the vulnerability to develop psychiatric disorders, such as anxiety, depression or drug 
addiction. 
In clinics, synthetic GCs are often prescribed in pregnancies in risk of pre-term labor, to 
ensure fetal lung maturation. Regardless of its beneficial effect, elevated levels of GCs during this 
period can lead to deleterious and permanent effects on brain function and development. The 
mesocorticolimbic dopaminergic circuit, also known as the ‘reward’ system, seems to be a key 
target of stress/GCs, since it has been shown that animals exposed to GC in utero (iuGC) have 
structural and molecular alterations in several brain regions of this pathway. Importantly, such 
changes may underlie the observed addictive-like behavior of iuGC animals. 
Vulnerability for addictive behavior may be modulated by individual emotional condition 
and/or specific personality traits. iuGC animals present anxious and depressive-like behavior, but 
less is known about their novelty-seeking and impulsivity traits, two behavioral dimensions that 
contribute substantially to drug-seeking behavior. In this perspective, we evaluated iuGC animals 
in novelty-dependent behavioral tests. iuGC animals did not present major differences in novelty-
induced locomotor activity nor in general exploratory behavior (Novelty Place Preference and 
Novel Object Recognition). However, iuGC rats explore familiar and novel objects similarly in the 
24h retention time test, suggesting long-term memory impairment. In addition, we assessed 
impulsive action, using the 5-Choice Serial Reaction Time Task (5-CSRTT) and impulsive choice, 
using the Delay Discounting (DD) test. Whereas no significant differences were found in 5-CSRTT 
performance, iuGC animals present alterations in the DD task. Since DD task is strongly 
dependent on the prefrontal cortex (PFC) and also the amygdala, we analyzed the neuronal 
activation pattern of these brain regions upon task performance. iuGC treatment induced 
significant changes in c-fos positive cell density in the orbitofrontal cortex, medial PFC and less so 
in the amygdala, which could potentially explain the observed behavioral differences. Altogether, 
our results suggest that iuGC treatment does not seem to affect novelty-seeking behavior, but it 
has an effect in impulsive choice, which may contribute for the observed enhanced drug-seeking 
behavior.  
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Efeitos da exposição pré-natal a glucocorticóides na impulsividade e 
comportamento de procura de novidade 
Resumo 
Exposição a stress pré-natal ou a níveis elevados de glucocorticóides (GC) podem 
resultar em alterações persistentes no sistema nervoso central, aumentando a vulnerabilidade 
para o desenvolvimento de doenças psiquiátricas tais como a ansiedade, depressão ou 
dependência de drogas.   
Na clínica, os GCs sintéticos são vulgarmente prescritos em casos de risco de parto 
prematuro, para assegurar a maturação pulmonar fetal. Independentemente do seu efeito 
benéfico, níveis elevados de GCs durante este período podem levar a efeitos nefastos e 
permanentes na função e desenvolvimento cerebral. O circuito mesocorticolímbico, conhecido 
como o sistema de recompensa, parece ser um alvo preferencial do stress /GCs, uma vez que 
foi demonstrado que animais expostos in útero a GCs (iuGC) têm alterações estruturais e 
moleculares neste circuito. De salientar que tais mudanças podem ser a base do 
comportamento aditivo observado nestes animais. 
A vulnerabilidade para o comportamento aditivo pode ser modulada pela condição 
emocional e/ou características da personalidade do indivíduo. Os animais iuGC são ansiosos e 
apresentam características do tipo depressivo, mas pouco se sabe sobre o seu efeito em 
características como a procura de sensação/novidade e impulsividade, duas dimensões 
comportamentais que contribuem substancialmente para o comportamento aditivo. Nesta 
perspectiva, estes animais foram avaliados em testes comportamentais baseados na resposta à 
novidade. Os animais iuGC não apresentam diferenças substanciais na atividade locomotora 
induzida pela novidade nem no comportamento exploratório geral (Novelty Place Preference e 
Novel Object Recognition). Contudo, os indivíduos iuGC exploram objectos familiares e novos de 
forma semelhante no teste com tempo de retenção de 24h. Adicionalmente, avaliámos a acção 
impulsiva, através do 5-Choice Serial Reaction Time Task (5-CSRTT) e a escolha impulsiva, 
utilizando o teste Delay Discounting (DD). O grupo iuGC apresenta alterações na tarefa DD, mas 
não na performance no 5-CSRTT. Como o teste DD é dependente do córtex pré-frontal (PFC) e 
da amígdala, foi analisado o padrão de activação neuronal destas regiões usando 
imunohistoquímica para c-fos. O tratamento iuGC induziu alterações na densidade de células c-
fos positivas no córtex orbito frontal e PFC medial, com menor efeito na amígdala, o que pode 
ajudar a explicar as diferenças observadas. Em suma, os nossos resultados sugerem que o 
tratamento iuGC não parece afetar o comportamento exploratório, mas tem um efeito deletério 
na memória de longo prazo. Em simultâneo, os animais iuGC apresentam maior escolha 
impulsiva, o que pode contribuir para a maior vulnerabilidade para comportamentos aditivos.  
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1. Introduction 
The maintenance of a dynamic equilibrium, or homeostasis, during exposure to internal 
or external threats, is required for life (Chrousos and Gold, 1992; Charmandari et al, 2005). 
These threats or stressors induce a cascade of reactions that reflect in a complex and constant 
adaptation of several endocrine, autonomic and behavioral systems that help preserve viability 
through change or allostasis (McEwen and Seeman, 1999).  
The stressor type influences the repertoire of neuronal populations that perceive it, as 
well as the molecular mediators that are involved in the adaptive response. A physical stressor, 
such as trauma, recruits brainstem and hypothalamic regions (Ulrich-Lai and Herman, 2009; 
Joëls and Baram, 2009), whereas a psychological one, e.g., social embarrassment, recruits brain 
regions that mediate emotion (the amygdala and the prefrontal cortex (PFC)), learning and 
memory (hippocampus) and decision making (PFC) (De Kloet et al, 2005; McEwen, 2007; Joëls 
and Baram, 2009). Though the type of stressor may differ, physical stressors often have 
psychological features and vice versa. In addition, the age of an individual affects the magnitude 
of the stress response, since the molecular cascades that are activated by stress in the 
hypothalamus and hippocampus in adult life differ from those activated in the infant phase, 
changing again with aging (Lupien et al, 2009; Joëls and Baram, 2009).  The duration of the 
stress also impacts the elicited response. The system is able to adapt with one type of stressor, 
whereas chronic stress can cause inhibition of neurogenesis, disruption of neuronal plasticity and 
neurotoxicity. Other aspects, such as sex and even genetic factors can also contribute to the 
diversity and impact of the stressors in the brain (Joëls and Baram, 2009). 
Studies in both animals and humans have shown that the brain is particularly sensitive to 
stress in the prenatal period and early childhood, since it undergoes important changes during 
these periods. Additionally, there seems to be a relation between exposure to early life stress 
(ELS) and increased reactivity to stress in adulthood, suggesting a ‘programming’ effect in the 
circuits involved in the stress response (Lupien et al, 2009).  
 
1.1. The stress response 
The stress response is mediated by two distinct systems, the sympathetic-
adrenomedullary (SAM) and the hypothalamic-pituitary-adrenocortical (HPA) systems 
(Frankenhaeuser, 1986; Stratakis and Chrousos, 1995). The SAM system is comprised by the 
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autonomic nervous system and upon stimulation, releases catecholamines, predominantly 
epinephrine, but also norepinephrine (NE) (Vollmer, 1996). NE and epinephrine increase heart 
rate, vasodilatation in muscles and constriction of blood vessels in the skin, ensuring blood 
supply to the brain and muscles, thus playing an important role in the fight/flight response. Even 
though neither of these two catecholamines are able to cross the blood brain barrier, alongside 
their peripheral action, the locus coeruleus produces NE in the brain, supporting vigilance and 
attention and participating in processes that activate the HPA axis (Morilak et al, 2005; Gunnar 
and Quevedo, 2007). Corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) are 
released by cells in the paraventricular nuclei of the hypothalamus, upon activation of the HPA 
axis (Figure 1) (Plotsky et al, 1993). These hormones act on the anterior pituitary, leading to the 
release of adrenocorticotropic hormone (ACTH), which interacts with receptors on the cortex of 
adrenal glands, stimulating the production and release of glucocorticoids (GC; cortisol in humans 
and corticosterone in rodents) and some mineralocorticoid steroid hormones, into the 
bloodstream (Plotsky et al, 1993; Stratakis and Chrousos, 1995; Checkley, 1996; Gunnar and 
Quevedo, 2007). Upon release of GCs, these hormones also participate in the termination of the 
stress response by exerting a negative feedback in the secretion of CRH and ACTH, in the 
paraventricular nuclei of the hypothalamus and the anterior pituitary, respectively. Also, the GCs 
feedback inhibition acts upon the medial prefrontal cortex (mPFC) and hippocampus, thus 
limiting the tissue exposure to GCs (Charmandari et al, 2005).  
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Figure 1. The anatomy of the HPA system and the important structures in its regulation (A). The activation (+) and negative 
feedback inhibition (-) pathways of the HPA system is also represented (B). Increase in glucocorticoids (GCs) is initiated by the 
release of corticotropin-releasing hormone/arginine vasopressin (CRH/AVP) from the paraventricular nucleus (PVN) in the 
hypothalamus. Through GCs, a negative feedback inhibition occurs in the pituitary, hypothalamus (HYP), and hippocampus (HC). 
ACTH, adrenocorticotropic hormone; AMY, amygdala; GABA, gamma aminobutyric acid; HC, hippocampus; HYP, hypothalamus; 
PFC, prefrontal cortex. Adapted from Gunnar and Quevedo, 2007. 
 
The Central Nervous System (CNS), through its activity, coordinates both the SAM and 
HPA systems. For short term periods, balanced activation of these systems tends to support 
adaptive functioning. However, over chronic activation, the suppressive impact of constant 
elevated, or even decreased, levels of GCs and frequent SAM responses can have deleterious 
effects on physical and mental health, affecting behavior as well as growth, metabolism, 
circulation, reproduction and the inflammatory/immune response, increasing the vulnerability to 
a variety of disorders, including heart disease, hypertension, type II diabetes, anxiety, depression, 
post-traumatic stress disorder (PTSD), eating and sleeping disorders and addiction (Chrousos 
and Gold, 1992; Charmandari et al, 2005; Gunnar and Quevedo, 2007; Chrousos, 2009). 
  
1.2. Stress and glucocorticoids action 
Glucocorticoids have a variety of effects in target systems in the organism, aiming to 
increase the availability of energy substrates and allow optimal adaptation to changes in the 
environment. Under basal conditions, GCs are secreted in a 24h circadian rhythm, with a 
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morning maximum concentration (circadian peak), that slowly declines throughout the day and 
night, with an abrupt elevation after the first hours of sleep (Sapolsky et al, 2000; Lupien et al, 
2005). Once released into general circulation, GCs enter the cytoplasm of cells throughout the 
body and brain, where they bind to two receptor subtypes: the high affinity mineralocorticoid 
receptor (MR), or type I receptor, and the low affinity glucocorticoid receptor (GR), or type II 
receptor (De Kloet, 1991). The activation of these receptors is responsible for the activation of 
transcription of genes with GC-responsive regions (Sapolsky et al, 2000). 
The presence of an enzyme, 11 Beta-hydroxysteroid dehydrogenase (11 β-HSD) prevents 
GCs from binding to MRs, by converting cortisol/corticosterone to its inactive form (cortisone/11 
dehydrocorticosterone). In the brain, 11 β-HSD is minimally expressed and, despite having an 
ability to bind to both MR and GR, GCs have higher affinity to MRs (80%-90% of MRs are occupied 
by GCs) in a basal condition (De Kloet, 1991; Gunnar and Vazquez, 2006). Conversely, GRs are 
occupied either at the peak of the circadian cycle or upon stimulation of the HPA axis by stress. 
Considering the distribution pattern of these receptors in the brain, MRs are exclusively present in 
the limbic system, such as the hippocampus, parahippocampal gyrus, amygdala, entorhinal and 
insular cortices, whereas GRs are present in the nucleus accumbens (NAcc) and cortical 
structures, such as the PFC, along with hypothalamus, hippocampus and parahippocampal gyrus 
(McEwen et al, 1986; Diorio et al, 1993; Lupien et al, 2005).  
The effects mediated by GRs are characterized as suppressive, considering that they are 
necessary for the termination of the HPA stress response and facilitate the recovery of cellular 
homeostasis (Sapolsky et al, 2000). However, when prolonged, these suppressive effects begin 
to exceed their benefit, ultimately leading to increased vulnerability to several neuropsychiatric 
disorders. 
 
1.3. Use of glucocorticoids in clinics 
Synthetic GCs are widely used in clinics for a broad range of disorders, due to their 
pleiotropic effects. Betamethasone (BET) and dexamethasone (DEX) are synthetic glucocorticoids 
commonly administered to pregnant women in case of premature delivery. This type of 
treatment, reported by Liggins and Howie (1972), has long been validated, since it promotes fetal 
lung maturation, ensuring the efficacy and safety against disorders, such as respiratory distress 
syndrome, reducing neonatal morbidity and mortality (Crowley, 1995). Besides the reduction of 
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respiratory distress syndrome occurrences, treatment with either BET or DEX is also known to 
reduce cases of intraventricular hemorrhage (Liggins and Howie, 1972) and congenital adrenal 
hyperplasia, the most frequent being the 21-hydroxylase deficiency (Lunghi et al, 2010), 
preventing genital masculinization in female fetuses. 
Despite the obvious beneficial effects of glucocorticoid usage, one cannot overlook the 
outcome and the long-term consequences that emerge from such hormone treatment, such as 
low birth weight, both in animal models (Nyirenda et al, 1998; Ikegami et al, 1997; French et al, 
1999) and humans (French et al, 1999; Newnham and Moss, 2001; Bloom et al, 2001), which 
escalate and are associated with the development of hypertension, insulin resistance, type 2 
diabetes and cardiovascular disease (Barker et al, 1993; Rich-Edwards et al, 1997; Curhan et al, 
1996a; Curhan et al, 1996b). 
These synthetic GCs differ from their endogenous equivalent in their chemical structure, 
pharmacokinetics and target specificity properties, exhibiting thus an intensified affinity to the GR 
than to the MR (Tegethoff et al, 2009) and possess an ability to cross the placenta easily. In 
normal conditions, fetal GC levels are much lower than maternal ones (Beitens et al, 1973; 
Klemcke, 1995) due to 11 β-HSD activity, that is also expressed in the placenta, and inactivates 
endogenous GCs. However, DEX and BET are poor substrates for 11 β-HSD, hence resulting in 
the crossing of the synthetic hormones through the placenta, from the mother to the fetus 
(Brown et al, 1996; Seckl, 2004), activating GR-induced transcription in the later (Welberg and 
Seckl, 2001). This early high exposure to GC can, potentially and persistently, affect the 
developing brain, programming it in a way that may predispose the system to disease (Welberg 
and Seckl, 2001). 
 
1.4. Early life stress and the ‘programming’ effects of glucocorticoids in the 
brain 
During the early life period, the developing brain is very susceptible and sensitive to a so-
called ‘programming’, i.e., modulation of fetal physiological and metabolic processes by a 
stimulus or an insult during a critical period of development (Barker, 2001). Increasing evidence 
revealed a major role played by the intra-uterine environment in the development of several adult 
diseases. Different early life stress episodes have also been linked  to increased  risk  for  the  
development  of  personality  disorders, attention  deficit  hyperactivity  disorder (ADHD), anxiety, 
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depression, schizophrenia and addictive disorders (Agid et al, 1999; Bernet and Stein, 1999; 
Weiss et al, 1999; Heim and Nemeroff, 2001; Dube et al, 2003;  Chapman et al, 2004). 
Exposure to stress or glucocorticoids of a pregnant female or even other types of extreme 
conditions, such as undernutrition, lead to an increase in maternal GC secretion (Cadet et al, 
1986; Dean and Matthews, 1999; Maccari et al, 2003). Since a part of the GCs cross the 
placental barrier and reaches the fetus, activity of the fetal HPA axis is increased, affecting brain 
development (Seckl, 2007). It is important to know that throughout pregnancy and fetal 
development, GCs are crucial and play an important role in the normal maturation of the 
developing CNS (Meaney et al, 1996) by initiating terminal maturation, remodeling axons and 
dendrites and cell survival (Meyer, 1983). However, prenatal treatment with GCs is also known to 
delay maturation of neurons, myelination, glia and vasculature (Hung et al, 2001a; Hung et al, 
2001b). Along with these effects, when in utero exposure to GCs is excessive, resulting in the 
programming of the HPA axis and subsequent impairment of the HPA axis function, different 
neurobiological pathways can be affected and altered. Additionally, alterations have been noted in 
the morphology, structure and number of various neuronal areas (Oliveira et al, 2006; Leão et al, 
2007; McArthur et al, 2005; Rodrigues et al, 2011; Oliveira et al, 2012). Several studies revealed 
that prenatal exposure to stress/GCs leads to neurodegeneration in hippocampus (Stein et al, 
1997) and anxiety-like behavior due to altered levels of CRH in the amygdala (Welberg et al, 
2001). Furthermore, a decrease in neuronal numbers in the nucleus accumbens (NAcc) is noted 
(Leão et al, 2007), along with an increase in the number of immature spines. Studies from 
Oliveira et al. (2012) demonstrated an increase in the volume and dendritic length of neurons of 
the bed nucleus of the stria terminalis (BNST), as well as a decrease in the volume of the 
basolateral nucleus of the amygdala (BLA) and central nucleus of the amygdala (CeA). Regarding 
the effects of prenatal exposure to GCs in behavior, individuals developed anxious-like behavior 
(Oliveira et al, 2006; Oliveira et al, 2012), depressive-like behavior (Roque et al, 2011) and 
addictive-like behavior (Rodrigues et al, 2011).  
Altogether these evidences pinpoint the mesocorticolimbic circuit as extremely sensitive 
to GC programming effects, which may explain the appearance of the above mentioned mood 
and reward disorders. 
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1.5. Mesocorticolimbic system and related behaviors 
The mesocorticolimbic system, otherwise known as the reward system, is responsible for 
the processing of the rewards, whether natural, such as sex and food (Kelley and Berridge, 2002) 
or addictive rewards, like drugs of abuse, and where dopamine (DA) plays a major role. 
Increasing evidence suggests that acute DA signaling is critical for the motivational reward, since 
it mediates the attribution of incentive salience to reward-related stimuli, increasing the 
motivation for the reinforcer (Berridge, 2007). It is important to mention the different dimensions 
in the reward system, namely the process of learning the occurrence of the reward, the hedonic 
impact of the reward (‘liking’) and the incentive salience or the motivation attributed to reward-
related stimuli (‘wanting’) to obtain a certain reward. In this way, when incentive salience is 
attributed to the reward-related stimulus, the brain perception of the reward is altered into a 
motivationally potent incentive (Berridge, 2007). Thus, the mesocorticolimbic dopaminergic 
system becomes a key component in the study of addictive behavior. 
The mesocorticolimbic circuit, usually divided in mesolimbic and mesocortical systems, 
arises from the ventral tegmental area (VTA), which projects to the PFC, controlling executive 
function and cognition, and the NAcc, amygdala and hippocampus, regulating memory, 
motivation, reward and addiction (Rodrigues et al, 2010).   
 The VTA neurons can be activated by stress and the dopaminergic projections to, not 
only the NAcc, but also the medial PFC (mPFC) are also a target for the stress hormone 
(Abercrombie et al., 1989; McEwen et al. 1986).  Studies developed by Leão and colleagues 
(2007) showed a decrease in proliferating cells in the NAcc core and shell and in the VTA that 
resulted in a reduction of the dopaminergic innervation in this system. Rodrigues et al. (2011) 
showed a decrease on the basal levels of DA in the NAcc and an increase on the mRNA and 
protein expression levels of dopamine receptor 2 (D2), but not dopamine receptor 1 (D1). A 
decrease on DA levels, along with an increase only in the mRNA expression level of D2, but not 
D1, was noted in the amygdala, after prenatal exposure to GCs (Oliveira et al, 2012).  All of these 
structural and molecular changes led to the development of behavioral alterations. Animals that 
were prenatally exposed to GCs revealed to be hyperanxious (Oliveira et al, 2006; Oliveira et al, 
2012), depressive (Roque et al, 2011) and are more vulnerable to the development of an 
addictive-like phenotype (Rodrigues et al, 2011). In this context, it is important to mention that 
there was a correlation between behavioral deficits of animals exposed to prenatal GCs and 
dopaminergic dysfunction, since that after stabilization of the DA levels (through the use of a DA 
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precursor), the drug-seeking behavior was reverted and expression levels of D2 were normalized 
(Rodrigues et al, 2011).  
 Dependent behaviors or addiction are attributed to different brain regions, resulting in a 
complex behavior. Studies from Leão et al. (2007) and Rodrigues et al. (2011) uncovered the 
deleterious effects of prenatal exposure to DEX in the mesolimbic ‘rewarding’ pathway, 
particularly in the NAcc, as aforementioned, highlighting new insights in the mechanism that 
underlies reward-related and addictive behavior. 
 
1.6. Impulsivity and novelty-seeking behavior in substance abuse disorders 
Substance abuse is defined by the American Psychiatric Association in the diagnostic and 
statistical manual of mental disorders (DSM-IV) as a maladaptive pattern of substance use 
leading to significant impairment, manifested by recurrent substance use that may culminate in 
several persistent and recurrent problems, such as increasing dosage intake and compulsive 
drug seeking that persists despite the outcome (1994). Individual genetic/epigenetic and external 
factors seem to contribute for the development of such disorder, even though the mechanisms 
can be substantially different. In this manner, it is plausible to assume that some individuals are 
more vulnerable when initially exposed to addictive drugs (Anthony et al, 1994) and prediction of 
drug intake escalation, followed by compulsive drug seeking and increased propensity to relapse 
after abstinence has been related to behavioral characteristics such as impulsivity and novelty-
seeking (Everitt et al, 2008; Verdejo-Garcia and Perez-Garcia, 2007).  
Impulsivity is a key characteristic of several psychiatric disorders, including personality 
disorders, mania, ADHD and drug addiction, as already mentioned, and is a complex 
multidimensional behavior (Evenden, 1999) that has been defined as an inability to wait, a 
tendency to act without forethought, insensitivity to consequences and an inability to inhibit 
inappropriate behaviors (Ainslie, 1975; Barkley, 1997; Barratt and Patton, 1983; Eysenck, 1993; 
Rachlin and Green, 1972). Thus, this trait can be divided into two categories: behavior that 
results from deficits in the ability to withhold responding, showing poor inhibitory control 
(impulsive action); and behavior that does not result from such inhibitory deficits but from an 
insensitivity to delay of gratification, delay aversion, leading to impulsive decision making, that is 
represented by increased preference for immediate reward over a large but delayed reward 
(impulsive choice) (Winstanley et al, 2006; Diergaarde et al, 2008).  
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Increasing evidence supports the important role of impulsivity in drug addiction and 
disturbances in inhibition of behavior that result from prolonged drug intake have been proposed 
to maintain compulsive drug intake (Jentsh and Taylor, 1999). Various studies reported that high 
impulsive behavior might predispose individuals to initiate or maintain drug seeking and taking in 
animal models (Krishnan-Sarin et al, 2007; Paulus et al, 2006) and humans (Dalley et al, 2007; 
Diergaarde et al, 2008; Perry et al, 2005). For instance, impulsive choice is increased in 
smokers as compared with nonsmoking individuals (Bickel et al, 1999; Mitchell, 1999) and an 
association between elevated impulsivity and increased self-administration behavior has been 
reported for cocaine (Dalley et al, 2007; Perry et al, 2005). However, the findings for a given 
drug have not always been consistent; as studies from Ortner et al. (2003) showed that alcohol 
reduced impulsive choice in humans, while Richards et al. (1999) found no effect of alcohol and 
other experiments revealed alcohol-induced impulsive choice in rats (Evenden and Ryan, 1999; 
Tomie et al, 1998). These discrepancies may in some cases be because the drugs have a 
situation and choice dependent effect (Cardinal, 2006). 
Considering that novelty/sensation seeking are constructs useful in predicting human 
risk-taking behaviors, it is plausible to link these traits with addictive behavior. Novelty is 
associated with events not previously experienced, as well as new combinations of familiar 
stimuli (Bevins, 2001). Different studies revealed an association between the sensation/novelty-
seeking trait and cocaine abuse or addiction (Franques et al, 2000; Franques, 2003; Kreek et al, 
2005). For that, individuals that are novelty/sensation seekers are also more prone to experience 
addictive drugs, similar to several risky activities (Zuckerman et al, 1990; Horvath and 
Zuckerman, 1993; Kalichman et al, 1994; Wills et al, 1994; Jonah, 1997; Sher et al, 2000; 
Zuckerman and Kuhlman, 2000; Woicik et al, 2009). Some individuals may present increased 
novelty-seeking behavior, predisposing them to consume drugs of abuse for the first time or 
increased impulsive behavior, presenting a higher probability to engage in dangerous behaviors 
(Belin et al, 2010). Regarding spontaneously high impulsive (HI) rodent studies, a significant 
escalation of intravenous cocaine and nicotine self-administration has been shown (Dalley et al, 
2007; Diergaarde et al, 2008) and, interestingly, no differences in anxious-like behavior nor in the 
reactivity to novelty were detected (Molander et al, 2011). Taking into account these results, it is 
possible to separate HI animals from the high responder (HR) phenotype described by Piazza 
and colleagues (1991) that revealed increased exploratory activity and a greater propensity to 
acquire drug self-administration. In this way, it is possible to differentiate the novelty-seeking 
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dimension from the impulsive one, despite the general preference of impulsive rats for novelty 
(Molander et al, 2011), since HI rats show persistent responding for cocaine despite punishment 
(Belin et al, 2008), together with an increased propensity to escalate sucrose-seeking behavior 
and intravenous cocaine and nicotine self-administration (Dalley et al, 2007; Diergaarde et al, 
2008, 2009). This indicates that impulsive rats may be more reactive to positive reinforcement 
than negative one, highlighting the trait-like impulsivity as a core behavior underlying vulnerability 
for stimulant addiction (Molander et al, 2011).  Alterations in novelty-seeking or sensation-seeking 
behaviors are also associated with a variety of psychiatric disorders including alcoholism and 
drug addiction (Zuckerman and Neeb 1979; Zuckerman 1990; Wills et al, 1994; Woicik et al, 
2009) and Belin and colleagues (2010) showed a clear distinction between two vulnerable 
phenotypes predisposing to cocaine addiction: a ‘drug use prone’ phenotype such as high 
responder which brings an individual to develop drug use and an ‘addiction prone’ phenotype, 
such as high-novelty-preference, which facilitates the shift from sustained to compulsive drug 
intake and addiction.  
Taken together, studies performed seem to point out that both novelty/sensation-seeking 
and impulsive traits are associated with addictive behavior, not necessarily independently from 
one and another, thus making imperative a behavioral assessment, in individuals prenatally 
exposed to GCs and with increased vulnerability to drug-seeking behavior, which we will tackle in 
the next section.    
 
1.7. Assessment of impulsive behavior 
The different aspects of impulsivity can be measured using paradigms that focus on 
different aspects of the impulsive response, dividing them in tasks that evaluate response 
inhibition, which involves premature or difficult to suppress actions (impulsive action) and 
impulsive choice response, that comprises actions that fail to take into account other outcomes 
and that may be sub-optimal. This type of behavior can be measured in experimental animals 
using tests that are based on equivalent tasks in humans (Dalley and Roiser, 2012).  
Assessment of impulsive choice is usually accomplished by performing a delay 
discounting (DD) task, where subjects are trained to choose between small immediate rewards 
and larger but delayed rewards (Cardinal et al, 2001). Moreover, abnormally steep delay 
discounting has been demonstrated in drug addicts, including alcoholics (Petry, 2001; Vuchinich 
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and Calamas, 1997), cocaine users (Coffey et al, 2003; Kirby and Petry, 2004), opiate users 
(Kirby and Petry, 2004; Kirby et al, 1999; Madden et al, 1997), and smokers (Bickel et al, 1999; 
Mitchell, 1999; Ohmura et al, 2005; Reynolds et al, 2004). 
Additionally, impulsive action can be evaluated by the 5-Choice Serial Reaction Time Task 
(5-CSRTT) paradigm, in which subjects are trained to detect the spatial location of a brief visual 
stimuli presented in one of five recesses in an operant chamber (Robbins, 2002), and, similar to 
the analogous performance test in humans, it evaluates sustained and selective attention. This 
form of impulsivity is associated with ‘restraint’ and defined by the inability of an individual to 
withhold a strong behavioral tendency (Schachar et al, 2007). Furthermore, impulsive action is 
measured by the number of premature or anticipatory responses made before the onset of the 
target stimulus and increases with the extension of the pre-stimulus interval.  
Correlational studies have been performed in order to associate questionnaire measures 
of impulsivity and performance on behavioral tests, such as delay discounting (Reynolds et al, 
2006) and further analysis of the behavioral measures revealed two independent latent variables: 
one corresponded to impulsive action measures and the other corresponded to impulsive choice 
measures (delay discounting; risk taking). Moreover, studies that scored individuals as ‘‘high’’ 
impulsive in the questionnaires have been reported to perform worse on decision-making tests 
(Crean et al, 2000; Franken et al, 2008).  
 
1.8. Assessment of novelty-seeking behavior 
The sensation/novelty-seeking behavior trait can be divided in different dimensions and 
can be studied in rodents both by high locomotor reactivity to a new inescapable environment, 
corresponding in different studies to the HR animal phenotype (Dellu et al, 1996; Blanchard et al, 
2009). However, they do not predict the vulnerability to switch from sustained drug use to 
addiction (Belin et al, 2008; Belin et al, 2010). Also, it is possible to assess high propensity to 
visit a new environment in a free-choice procedure, i.e. novelty-induced in a conditioned place 
preference (CPP) apparatus, which are typically seen in the high novelty preferring (HNP) 
phenotype (Bardo et al, 1996; Cain et al, 2005) or even the preference for a novel object, in 
comparison to a familiar one (Bardo et al, 1990; Molander et al, 2011). These two behavioral 
measurements are suggested to be different (Bardo et al, 1996; Cain et al, 2005) and predict 
different dimensions of drug reward (Bardo et al, 1996). In this way, it has been shown that HR 
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animals are more vulnerable than low responder (LR) ones in their propensity to acquire drug 
self-administration (Piazza et al, 1990; Piazza et al, 2000), whereas HNP animals differ from 
their low novelty preferring (LNP) littermates in their vulnerability to express place preference for 
amphetamine (Bardo et al, 1996) but not in their propensity to acquire drug self-administration 
(Klebaur et al, 2001). Hence, these different novelty traits may differently contribute to the 
vulnerability to addiction, revealing a dissociation between the propensity to acquire drug 
administration and compulsive drug use (Belin et al, 2008). 
Moreover, correlational studies between novelty and the different forms of impulsive traits 
have been performed to establish whether a particular form of impulsivity was associated more 
strongly with novelty-seeking than other forms of impulsivity. It has been recently shown that 
animals with high reactivity to a novel environment revealed an increase in the approach to food 
and cocaine-predictive cues compared with low responder rats and were also less impulsive on a 
delay discounting task (Flagel et al, 2010).  However, in a measure of impulsive action, they have 
been shown to be more impulsive (Pattij and Vanderschuren 2008; Winstanley et al, 2006). This 
distinction is important and may indicate multiple predisposing determinants of the propensity to 
drug self-administration (Molander et al, 2011). 
Taking into account the possible impact that stress may have in decision making and 
personality traits of individuals, we decided to evaluate how ELS affects traits associated with 
drug addiction, such as impulsive and novelty seeking traits and identify the alterations in 
neuronal activation of several areas involved in these types of behavior.  
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2. Objectives 
High exposure of GCs, during the prenatal period, has permanent and persistent effects 
in the CNS, culminating in increased vulnerability to addictive behavior. Yet, little is known about 
the traits that may underlie this increased propensity to develop drug addiction. In this context, 
we aimed to evaluate behavior traits that may explain the observed increased vulnerability to 
drug-seeking behavior in animals that received synthetic GCs in utero (iuGC). Our main goals 
were to: 
 Assess the effect of iuGC exposure in novelty-seeking behavior using different 
paradigms, namely Locomotor Reactivity to a novel environment, Novelty Place 
Preference (NPP) and Novel Object Recognition (NOR); 
 
 Unravel the potential impact of prenatal exposure to iuGC in impulsive behavior, 
through 5-Choice Serial Reaction Time Task (5-CSRTT) and Delay Discounting 
(DD) task;  
 
 Search for alterations in the activation pattern of several brain regions associated 
with DD, using c-fos staining. 
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3. Materials and Methods 
3.1. Animals and treatment 
Adult female pregnant Wistar han rats (Charles River Laboratories, Barcelona, Spain) 
were individually housed under controlled conditions (light/dark cycle of 12/12h with lights on at 
08:00h and ambient temperature of 22ºC±1ºC) with food and water ad libitum. Subcutaneous 
injections of dexamethasone (iuGC animals, 1mg/kg, Sigma-Aldrich, St. Louis, MO, USA; n=3/4 
pregnant female animals) or vehicle (control; CONT animals; n=3/4 pregnant female animals) 
were administered on gestation days 18 and 19. Progeny were separated according to gender 
and prenatal treatment (either CONT or iuGC animals) on postnatal day 21 and handled daily for 
5-10min for a week before behavioral testing. 
Subjects were male offspring, 3 months old at the start of the experiment, and were only 
food-deprived to approximately 85% of their free feeding weight until the end of the 5-Choice 
Serial Reaction Time Task (5-CSRTT) or the Delay Discounting (DD) task procedures, with food 
made available at the end of the experimental day.  Control and iuGC animals used for Novelty 
reactivity in an Open Field (OF), Novelty Place Preference (NPP) and Novel object recognition 
(NOR) were selected from one cohort of rats (n=40). Twenty animals were screened in the 5-
CSRTT and an additional group of rats (n=20) were subjected to the DD task. 
All experiments were performed in accordance with the local regulations (European 
Union Directive 2010/63/EU) and National Institute of Health (NIH) guidelines on animal care 
and experimentation. 
 
3.2. Behavioral assessment 
3.2.1. 5-Choice Serial Reaction Time Task 
3.2.1.1. Apparatus and training 
Two identical automated operant 5-CSRTT chambers (25 x 25 x 30cm), housed in 
ventilated and sound attenuating boxes, were used. Each chamber contained five square holes 
(2.54 x 2.2 x 2.25cm), each fitted with a photocell beam to detect nose pokes and a stimulus 
light positioned above, located on a curved rear wall. On the opposite wall, 45mg food pellets 
(Bio-Serve, Frenchtown, NJ) could be delivered into a magazine by a dispenser. Chamber 
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illumination was provided by a 100-mA house light located at the center of the roof. Control of 
the apparatus and data collection was performed by a PC with TSE software. 
Rats were trained according to the protocol described by Muir et al. (1999). For the first 
two days, food pellets were made available in the magazine and response apertures were 
covered with metal caps for 15min. In the next two sessions, the metal caps were removed from 
apertures and several food pellets were placed in each hole as well as within the magazine. 
Animals were allowed to explore for 30min. During the fifth session the test schedule was 
implemented.  
 
3.2.1.2. 5-CSRTT assessment 
The test protocol consisted of illumination of the house light and delivery of a single food 
pellet to the magazine. The trial was initiated by the rat performing a magazine entry to collect 
this pellet. After a 3-5s inter-trial interval (ITI), the light of one of the holes was illuminated for a 
short period. The light stimulus was presented randomly and in an equal number of times in 
each of the ﬁve holes during each daily session. Sessions consisted of 100 trials or were 
terminated after 30min of testing and the target parameters for each session were: stimulus 
duration, 0.5s; limited hold period, 5s; ITI and time-out period, 5s.  Responses or nose pokes 
performed in this aperture were rewarded with the delivery of a food pellet and a correct 
response was recorded. If an animal executed additional nose pokes, perseverative responses 
were recorded and resulted in a 3-5s period of darkness (time-out). Further nose pokes in the 
apertures during this period restarted the time-out. An incorrect response was recorded when an 
animal performed a nose poke in a non-illuminated hole during the signal period and failures to 
respond within the limited hold period were recorded as omissions. In both situations the 
chamber entered the ITI state and any additional responses in this period restarted the time-out. 
A response in the food magazine after the delivery of a food pellet, or after the time-out period, 
initiated the next trial and further entries in the magazine during the ITI or time-out periods were 
recorded but had no further consequences. Responses in the apertures during the ITI were 
recorded as anticipatory responses and, as in previous situations, resulted in a time-out period. 
Also, further responses during this period of darkness restarted the time-out. The end of a test 
session was signaled by extinguishing all the lights (Figure 2). 
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For the ﬁrst session of training, the stimulus duration and limited hold periods were both 
set at 60s, and the ITI and time-out periods set at 3s. These variables were altered on 
subsequent trials (stimulus duration (SD): 30s, 10s, 2s, 0.5s) according to the individual 
performance of each animal, until the target set of task parameters could be instituted. The 
animals were trained to a criterion of, at least 80% correct responses and <20% omissions within 
the 30min session time, when target parameters were attained on 2 consecutive days. When 
animals attained the target set of stimulus duration parameter of 0.5s for 4 consecutive days, a 
session with a stimulus of 0.25s was performed. However, the majority of the animals did not 
reach the 0.5s stimulus parameter of the task (only four animals successfully reached this 
variable, while the rest was still being tested). Several behavioral measures were recorded for 
assessment of the task: i) Accuracy - Measured as the proportion of responses that were correct 
(number of correct responses/total number of responses) and expressed as a percentage; ii) 
Speed - Speed was measured as latencies: the ﬁrst was the latency to respond correctly (time 
between the onset of the visual stimulus and the point at which the nose of the animal breaks the 
photocell beam of the hole and the second was the magazine latency (time between performance 
of a correct response and the magazine entry to collect the food pellet); iii) Anticipatory 
responses - Number of responses in the apertures during the ITI state; iv) Perseverative 
responses - Additional nose pokes in the holes following the initial response in an aperture; v) 
Omission - Number of trials on which no response was made during the limited hold period. 
Animals received one session per day, for a total of 50 sessions. 
 
 
Figure 2. Schematic representation of the 5-Choice Serial Reaction Time task. Animals are trained to respond to a brief stimulus 
(visual cue) that has duration of 60s, 30s, 10s, 2 s and 0.5s, according to the phase of training, and may appear randomly in one 
of the 5 apertures. This stimulus is predictive of a food reward, since a correct response towards the stimulus would result in the 
delivery of a food pellet. Animals may respond prematurely by performing an action before the end of the inter-trial interval (ITI) 
period (impulsive action) or they may have a perseverative response when performing repeated nose pokes in the same hole. 
Adapted from Eagle and Baunez, 2010. 
 
24 
 
3.2.2. Locomotor activity in a novel environment 
Locomotor activity was measured using an Open Field (OF) arena (43.2 x 43.2cm) 
equipped with two horizontal photocell beams situated 1cm from the floor that automatically 
registered activity (Med-Associates, St. Albans, VT, USA). Animals were placed in the center of the 
arena, an unfamiliar environment to them, and their ambulatory activity was recorded over a 2h 
period. The total number of photocell beam breaks was used as indicator of reactivity to the novel 
environment. Additionally, the number of rearings, time and distances in the central and 
peripheral areas were recorded. 
 
3.2.3. Novelty place preference 
The place preference apparatus consisted of two equally sized compartments  (28 × 22 x 
21cm) with distinct cues separated by a central neutral grey area (13 × 22 × 21cm), with two 
opposite entrances that could be closed by sliding doors (Med-Associates, St. Albans, VT, USA). 
One of the compartments had white walls and a mesh floor and the other had black walls and a 
grid floor. All compartments were equipped with photocell beams to record locomotor activity, 
number of visits and time spent in each compartment. Briefly, each animal was placed in the 
central grey area for 5min and allowed to explore one of the compartments for 30min in order to 
define the familiar compartment. The familiar compartment was counterbalanced for both groups 
of animals and animals were habituated for 2 consecutive days. During the test phase (day 3), 
subjects were placed in the central grey area for 5min, after which the sliding doors were opened 
to let the animal freely explore both compartments for 15min. The time spent in the new 
compartment was used as index of novelty preference. 
 
3.2.4. Novel object recognition 
The novel object recognition protocol was adapted from Bevins and Besheer (2006). The 
setup consisted of two rectangular dark chambers (50 x 50 x 100cm) and sessions were 
recorded using a video camera placed right above the apparatus. Animals were first habituated to 
the chambers for 10-15min. Each trial was composed by two phases, a sample phase and a 
choice phase. In the first, two identical to-be-familiarized objects (O1 and O2) were placed in the 
back left and right corner of the apparatus and each animal, placed facing away from the objects, 
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was allowed to explore them for a total of 3min. The second choice phase started after a delay of 
1h (Short-term memory assessment), with animals maintained in their home cage. In this phase, 
one of the familiar objects (e.g. O1) was replaced with a novel object (N). The trial ended when 
animals had explored both objects, for 2min. Animal nose directly contacting the object or 
directing it towards the object at a distance of ≤2cm was used as an indicator of object 
exploration. This protocol was repeated for Long-term memory assessment by altering the delay 
time between phases to 24h. 
 
3.2.5. Delay discounting task 
3.2.5.1. Apparatus and training 
Two identical standard operant chambers (30.5 x 24 x 21cm; Med-Associates, St. 
Albans, VT, USA), enclosed in sound-attenuating boxes and equipped with ventilation to mask 
outside noise, were used. Each operant chamber contained a central food magazine, with two 
retractable levers with a 2.8W round stimulus light above each lever, positioned on each side of 
the magazine. A photocell beam was fitted in the magazine to detect head entry and, on the top 
center of the opposite wall, a single 100-mA house light provided illumination. 45mg food pellets 
(Bio-Serve, Frenchtown, NJ) were delivered by a pellet dispenser into the magazine. The 
apparatus was controlled by MedPC-IV software (Med-Associates, St. Albans, VT, USA) running in 
a PC connected to the chambers and all experimental data were recorded. 
Training protocols were adapted from Cardinal et al. (2000) and Floresco et al. (2008). 
On the first day, animals were placed in the operant chambers where two to three pellets were 
already placed in the magazine and on the active lever. The first stage of training consisted of an 
instrumental task of continuous reinforcement (CRF) in order to obtain a food pellet. Animals 
were trained under a fixed ratio 1 schedule to respond first on the left lever then the right one 
(left/right levers counterbalanced between subjects), the criterion being 50 presses in 30min 
sessions. Once this stage was completed, animals were trained to make a head entry into the 
magazine to trigger lever presentation for 10s. A training session consisted of 90 trials and began 
with the chamber in darkness and both levers retracted (defined as inter-trial (ITI) state). Each 
trial began every 40s and with illumination of the house light. The animal was required to make a 
head entry within 10s to extend one lever or an omission would be recorded and the chamber 
returned to darkness. A lever was presented for 10s and if the animal failed to respond, the lever 
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retracted and the chamber darkened. However, if a response occurred, the lever retracted, a 
single pellet was delivered immediately into the magazine and the house light turned off after 
reward retrieval and for the rest of the inter-trial state. The left or right lever was presented once 
in a random order, with no more than two consecutive presentations of the same lever. Animals 
were trained to a criterion of 80 or more successful trial per session. 
 
3.2.5.2. Delay discounting assessment  
Each session began with the chamber in darkness and levers retracted. A session 
consisted of 4 blocks of 12 trials and lasted 56min and each trial lasted 70s. Session blocks 
initiated with two forced choice trials, and began with illumination of the house light. After an 
initial head entry, one of the two levers was presented randomly. These forced trials were 
followed by ten free choice trials where both levers were extended. As in training sessions, 
animals were required to perform a head entry or an omission would be recorded (type 1) and 
the chamber entered the ITI state (house light off until the beginning of the next trial). One of the 
levers was designated the immediate lever (Lever 1), the other one the delayed lever (Lever 2) 
(counterbalanced left/right) and lever presentation lasted 10s (if the animal failed to respond, an 
omission was recorded (type 2) and the chamber returned to the ITI state). Choice of Lever 1 
originated an immediate delivery of a single pellet reward, whereas Lever 2 originated a large 
delivery of four pellets following a delay. For the first block of trials, a response on either lever led 
to an immediate reward (0s). The following blocks increased the delay period in 15s intervals, 
such that in the second block, a response on Lever 2 resulted in large reward delivery after a 15s 
interval and in the third and fourth block the delay was 30s and 45s, respectively. After a lever 
press and during the delay, the stimulus light, positioned above Lever 2, was turned on until 
reward delivery, serving as a cue to signal the duration of the delay.  After reward retrieval, the 
house light was turned off and the chamber entered the ITI state for the remainder of the trial. 
Animals received one session per day, for a total of 21 sessions (Figure 3A and 3B).  
A similar version of the DD test was also performed. Here, the number of blocks of trials 
was increased to 5, with increasing delays throughout blocks. Again, for the first block of trials, a 
response on either lever, despite being the delayed or immediate lever, led to a delivery of a 
reward with no delay time (0s). The next block increased the delay time by a 5s interval and, as 
mentioned before, a response on Lever 2 caused a large reward delivery after that period. The 
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delay of the third block was 10s, 15s in the fourth block and, lastly, 30s in the fifth block. 
Animals received one session per day, for a total of 28 sessions. 
 
 
 
Figure 3. Schematic representations of the Delay Discounting task. (A) Outline of the Delay Discounting task, showing the basic 
structure of individual trials. (B) Animals are required to do a nose poke in order to start a trial and, after lever presentation, they 
have to choose to press a lever, between a small, but immediate reward lever and a large, but with delayed delivery, reward lever. 
As the session progresses, the delay time in each block increases (block of trials with 0s, 15s, 30s and 45s delay time). After 
collection of the food reward, the chamber returns to a state of darkness, the inter-trial interval, until the next trial begins (each 
trail lasts for 70s to ensure that animals that complete trials with no delays do not earn greater numbers of rewards by 
completing greater numbers of trials). (B) Adapted from Eagle and Baunez, 2010. 
 
3.3. Histological procedures 
3.3.1. Preparation of tissue for analysis 
Nine months old CONT and iuGC subjects were deeply anesthetized with sodium 
pentobarbital, after 60min of exposure to the operant chambers, with 45mg pellets made 
available (n=4, for each group), or after performing DD task (n=6, for each group). Afterwards, 
animals were transcardially perfused, with 0.9% saline solution for about 5min, followed by 4% 
paraformaldehyde solution for 20min. Brains were carefully removed and immersed in 4% 
paraformaldehyde solution for 2h at room temperature, before being transferred to a 8% sucrose 
solution (Panreac, Barcelona, Spain) at 4ºC, for a minimum of 48h. 
Coronal sections of 50µm were serially cut in a vibrotome (Leica VT 1000S, Nußloch, 
Germany) and those of interest, selected for further histological processing. 
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3.3.2. Immunohistochemistry for c-fos detection 
Induction of immediate early gene expression, such as c-fos, has long been accepted as 
a marker of neuronal activation and correlated with the activation of brain areas putatively 
involved in different actions, following external or internal stimuli (Herrera and Robertson, 1996; 
Puurunen et al, 2001; Lin et al, 1996). 
In order to detect c-fos expression, slices containing OFC (dorsolateral OFC (dlOFC), 
lateral OFC (lOFC), ventral OFC (vOFC) and medial OFC (mOFC)) and mPFC (Anterior Cingulate 
cortex (ACC), Prelimbic cortex (PLC), Infralimbic cortex (ILC)) subregions and amygdala (central 
nucleus of the amygdala (CeA) and basolateral nucleus of amygdala (BLA)) were selected and 
submitted to a free floating immunohistochemical procedure adapted from Dragunow et al. 
(1987). Briefly, brain slices were rinsed in phosphate–buffered saline (PBS; 0.1M, pH 7.2) and 
endogenous peroxidases activity was inhibited by incubating slices with 3.3% hydrogen 
peroxidase in PBS for 30min. Cellular membranes were permeabilized in a series of PBS-T (0.3% 
Triton X-100 (Sigma-Aldrich, St. Louis, MO, USA)  in PBS, 0.1M, pH 7.2) washes. After blocking 
with a solution containing 2.5% fetal bovine serum in PBS-T for 2h, sections were incubated with 
rabbit anti-c-fos (Ab-5) (4-17) polyclonal antibody (Calbiochem, USA) at 1:2000 dilution in 2% 
fetal bovine serum and PBS-T, overnight at room temperature. Afterwards, slices were washed in 
PBS-T, following incubation with a biotinylated swine anti-rabbit IgG secondary antibody 
(DakoCytomation, Denmark) at 1:200 dilution, for 1h at room temperature. Sections were then 
rinsed in PBS-T and reacted with avidin-biotin complex solution (Vectorstain Elite, Vector, USA), 
for 1h, at 1:200 dilution. The bound chromogen was revealed using 50% 3.3-diaminobenzidine 
(DAB; Sigma-Aldrich, St. Louis, MO, USA) and 0.02% hydrogen peroxide in Trizma base solution 
and reaction was finalized by a series of rinses in PBS. Finally, slides were mounted, 
counterstained with diluted hematoxylin and coverslipped with Entellan (Merck, USA) for 
microscopic observation.  
 
3.3.3. Quantification of c-fos staining 
The neuronal activation of the OFC (dlOFC, lOFC, vOFC and mOFC), mPFC (ACC, PLC 
and ILC) and amygdala (CeA and BLA) were outlined according to the rat brain atlas of Paxinos 
and Watson (2007) and matched as closely as possible based on landmarks and 
cytoarchitectural differences. The distance of the brain regions counted from bregma ranged 
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from: 5.64mm to 3.24mm for vOFC and mOFC; 5.64mm to 4.20mm for mOFC; 5.16mm to 
4.68mm for dlOFC; 4.20mm to 2.52mm for ACC; 5.16mm to 2.52mm for PLC; 3.72mm to 
2.52mm for ILC; and -1.56mm to -2.64mm for CeA and BLA. The quantification was done by 
sampling each of the regions selected using counting frames superimposed over the region. The 
size of the counting frames was 0.0025mm2 and the percentage sampled with respect to the 
total area of the brain regions selected was 20%. c-fos positive cells were identified on the basis 
of a brown reaction product confined to cell nucleus, thus presenting a circular/oval shape with a 
clear brown staining. Counting of c-fos positive nuclei was performed using Visiopharm Integrator 
System software (Visiopharm, Copenhagen, Denmark) and a  camera  (PL- A622,  Ontario,  
Canada)  coupled  to  a  motorized  microscope  (BX51TF,  Olympus, Tokyo, Japan). Finally, cell 
density (c-fos positive nuclei per mm2) for each brain area was calculated. 
 
3.4. Data analysis 
Statistical analysis was conducted using GraphpPad Prism 5 and IBM SPSS Statistics 19. 
Normality of all data sets was assessed using Kolmogorov-Smirnov test. Since equal variance or 
normality was assumed (data not shown), parametric tests were used throughout the analysis of 
the behavioral data. Differences between two groups were compared using Student’s t-test or 
analysis of variance (ANOVA) for comparing more than two groups. Regarding behavior results 
from locomotor activity, 5-CSRTT and DD task, data was subjected to two-way repeated measures 
ANOVA. Significant effects produced from analysis were compared via post hoc Bonferroni’s t 
test. For results from the histological analysis, normality of variances was not assumed and 
nonparametric tests were used (Mann-Whitney for comparing two groups). All data are presented 
as mean ± standard error (SEM) and, for each CONT and iuGC group, n represents the number 
of animals used. Differences were considered to be statistically significant when p ≤ 0.05.  
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4. Results 
4.1. Prenatal exposure to GCs does not alter locomotor reactivity to a novel 
environment 
Adult male progeny of dams treated with either 1mg Kg -1 of DEX (iuGC) or vehicle (CONT) 
on gestation days 18 and 19 were used. To evaluate novelty reactivity, the number of ambulatory 
counts was compared between groups (CONT and iuGC) in an open field apparatus. As shown in 
Figure 4, both groups decreased the number of ambulatory counts throughout the 120min of 
testing. 
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Figure 4. Novelty-induced locomotor reactivity in animals prenatally exposed to GCs. CONT and iuGC subjects did not present 
major differences in their locomotor response to a novel inescapable environment, with the exception of the first 10min in which 
iuGC had decreased ambulatory counts. Locomotor activity is represented as the mean of ambulatory counts, performed during 
the test session. Error bars represent SEM. n=24/group. **p<0.01. 
 
Repeated measures analysis revealed no effect of group (F(1, 473) = 2.235,  p = 0.142). 
However, for the first 10min of testing, CONT group showed an increased locomotor activity, or 
ambulatory counts, in comparison to the iuGC group (Bonferroni corrected t-test: t = 3.472, p < 
0.01). 
Additional parameters were analyzed to assess the effect of prenatal exposure to GCs in 
locomotor reactivity, namely the number of rearings and percentages of distance and time. iuGC 
animals did not present any differences in the total number of rearings (t(41) = 1.287, p = 0.205; 
Figure 5A) nor in the assessment of this parameter along the 120min of the trial (F (1, 440) = 2.483,  
p = 0.123; Figure 5B).  
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Figure 5. Number of rearings performed during assessment of locomotor activity in an Open Field apparatus. (A) Total number 
of rearings. (B) Number of rearings counted during the course of the locomotor reactivity test. No differences were found between 
groups. Rearings represented as the mean of vertical counts performed during the test session. Error bars represent SEM. 
n=24/group. 
 
Regarding the percentage of the distance travelled in both central and peripheral areas of 
the Open Field (OF) arena, both groups displayed an increase in distance in the central area 
when compared to the peripheral zone (F(3, 79) = 20.91, p < 0.0001; Bonferroni corrected t-test 
CONT: t = 6.721, p < 0.001; Bonferroni corrected t-test iuGC: t = 4.189, p < 0.001; Figure 6A). 
Analysis of the percentage of time spent in the central and peripheral areas revealed an effect of 
GC prenatal treatment (F(3, 79) = 19.70, p < 0.0001; Figure 6B). iuGC animals showed an increase 
in the time spent in the peripheral area in comparison to the central one (Bonferroni corrected t-
test: t = 7.511, p < 0.001; Figure 6B). Additionally, a decrease in the time spent in the central 
area was found in the iuGC group when compared to the CONT group (Bonferroni corrected t-
test: t = 2.822, p < 0.05; Figure 6B) and iuGC animals spent more time in the peripheral area 
than the CONT group (Bonferroni corrected t-test: t = 2.822, p < 0.05; Figure 6B). 
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Figure 6. Parameters of locomotion and exploratory activity in animals prenatally exposed to GCs. (A) Percentage of distance 
travelled in central and peripheral areas of the Open Field arena. Both groups display an increase in the distance travelled in the 
central area. (B) Percentage of time spent in central and peripheral areas. No differences were found between groups. iuGC 
animals spend less time in the central area than CONT animals. Error bars represent SEM. n=24/group. 
 
4.2. Effects of prenatal GC exposure in novelty-seeking behavior 
Animals were subjected to Novelty Place Preference (NPP) and Novel Object Recognition 
(NOR) tests to further assess novelty-seeking behavior. Regarding NPP, ANOVA analysis revealed 
differences between groups (F(3, 132) = 5.411, p = 0.0015; Figure 7). CONT animals explored the 
novel compartment for a significantly longer period of time when compared with the time spent 
exploring the familiar compartment, which was not observed in the iuGC group (Bonferroni 
corrected t-test; CONT: t = 3.640, p < 0.01; iuGC: t-test t = 1.698, p > 0.05; Figure 7). No 
significant differences were found between both groups in the total time spent in the novel or the 
familiar compartment. 
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Figure 7. Preference of CONT and iuGC animals for the novel and familiar compartments. CONT animals spent more time 
exploring the novel compartment in comparison to the familiar one, contrary to iuGC animals that do not present differences, as 
they spend the same amount of time in both compartments. Bars represent the mean duration of time spent in each 
compartment ± SEM. nCONT=35; niuGC=39. **p<0.01. (Familiar vs. Novel compartment) 
 
Taking into account the flexibility of the NOR test, animals performed two versions of the 
test that comprised a delay time of 1h and 24h between phases, allowing an assessment of the 
condition of the short-term memory and long-term memory, respectively. Concerning the NOR 
protocol with a 1h delay time, during initial sampling phase, both CONT and iuGC groups spent 
the same amount of time exploring the object (t71 = 0.3536, p = 0.725; Figure 8A). Moreover, 
both CONT and iuGC animals explored the novel object, during choice phase, for a significantly 
longer period of time than the familiar object (F(3, 134) = 26.28, p < 0.0001; Bonferroni corrected t-
test CONT: t = 8.436, p < 0.001; Bonferroni corrected t-test iuGC: t = 2.722, p < 0.05; Figure 
8B), though this was more evident in the control group. 
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Figure 8. Effect of prenatal exposure to GCs on two versions of a novel object recognition test. (A) Total time exploring the object 
in the sample phase of the NOR test with a 1h delay time between phases. (B) Novel object recognition with a 1h delay time 
between phases. Both CONT and iuGC animals spent more time exploring the novel object, in the choice phase. (C) Total time 
exploring the object in the sample phase of the NOR test with a 24h delay time between phases. (D) Novel object recognition with 
a 24h delay time between phases. In the choice phase, only CONT animals spent more time exploring the novel object, indicating 
a disruption of NOR in iuGC animals. Bars represent means ± SEM. (A), (B) nCONT=35; niuGC=39; (C), (D) nCONT=11; niuGC=15. 
*p<0.05, **p<0.01, ***p<0.001. (Familiar vs. Novel object) 
 
As presented in Figure 8C, during the sample phase of the 24h delay version of the NOR 
test, no differences were observed for both groups (t24 = 0.1301, p = 0.898). ANOVA analysis 
showed a significant difference between groups (F(3, 36) = 33.99, p <0.0001; Figure 8D), in the 
choice phase, with CONT animals spending significantly longer period of time exploring the novel 
object than the familiar one (Bonferroni corrected t-test: t = 9.831, p < 0.001; Figure 8D). 
However, iuGC animals did not differ in their time exploring either object (Bonferroni corrected t-
test: t = 1.850, p > 0.05; Figure 8D), indicating a disruption in novel object recognition and, 
possibly, long-term memory impairment. Also, significant differences between CONT and iuGC in 
the time exploring the familiar and novel objects was detected, during the choice phase 
(Bonferroni corrected t-test Familiar: t = 5.253, p < 0.001; Bonferroni corrected t-test Novel: t = 
3.303, p < 0.05; Figure 8D). 
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4.3. Impulsive choice but not impulsive action is altered in animals exposed to 
prenatal GCs 
The characterization of traits, such as drug-seeking behavior, has been associated with 
impulsiveness, besides novelty-seeking behavior. Considering the complexity of such feature, a 5-
Choice Serial Reaction Time Task (5-CSRTT) and a Delay Discounting (DD) protocol were 
performed, in order to assess the two dimensions of impulsive trait: impulsive action and 
impulsive choice, respectively. 
For the purpose of this thesis, in the 5-CSRTT, we evaluated the anticipatory responses, 
omissions and accuracy levels, to further assess impulsivity/impulsive action (or the ability to 
withhold a response) and the level of motivation and attention, respectively. 
No detectable differences in the performance of CONT and iuGC animals during training 
at each stimulus duration (SD; 60s, 30s, 10s, 2s and 0.5s) were found. In Figure 9, it is depicted 
the data from the last two sessions of task performance of different SDs (60s, 30s, 10s and 2s) 
and the last four sessions of training of 0.5s SD. At each SD, there was no significant main effect 
for group in the percentage of accuracy (Table 1; Figure 9A).  
 
Table 1. Summary table of the 5-Choice Serial Reaction Time Task measurements of 
percentage of accuracy, percentage of omissions and anticipatory responses. Representation  of  
the  statistical  analysis  (comparison  between  CONT  and  iuGC animals). 
  Statistics 
  CONT x iuGC (F, p) 
  Accuracy Omissions 
Anticipatory 
responses 
60s F(1,36) 0.149, 0.702 F(1,36) 3.399, 0.074 F(1,36) 0.7766, 0.384 
30s F(1,36) 0.000, 1.000 F(1,36) 15.58, 0.0004*** F(1,36) 0.3567, 0.554 
10s F(1,36) 1.904, 0.176 F(1,36) 1.833, 0.179 F(1,36) 3.492, 0.070 
2s F(1,36) 0.8588, 0.360 F(1,36) 2.052, 0.161 F(1,36) 0.05207, 0.821 
0.5s F(1,72) 2.4747, 0.102 F(1,72) 1.470, 0.229 F(1,72) 0.06909, 0.793 
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Figure 9. Performance of CONT and iuGC animals in the 5-Choice Serial Reaction Time Task. Shown is the different stages of 
training with stimulus durations of 60s, 30s, 10s, 2s and 0.5s, for 3 different measurements: (A) Percentage of accuracy 
(number of correct responses/total number of responses); (B) Percentage of omissions (number of trials that resulted in no 
response); (C) Percentage of anticipatory responses (number of responses in the apertures during the ITI state). All 
measurements showed no major differences between groups, except during SD of 30s in (B). Results are shown as means ± 
SEM. nCONT=10; niuGC=10. ***p<0.001.  
 
Regarding the percentage of omissions, no significant differences were found within 
groups (Table 1; Figure 9B). However, this measurement showed a statistically significant effect 
for training with a 30s SD between both groups (Table 1; Figure 9B). Despite this early difference 
between groups, as training progressed, that same effect disappeared, leading to a similar 
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response between groups. The final behavioral parameter measured in the 5-CSRTT was 
anticipatory or premature responses, where ANOVA analysis revealed no significant differences 
between both CONT and iuGC animals (Table 1; Figure 9C). 
In order to assess impulsive choice, animals performed a delay discounting task. As time 
progresses, a difference between the CONT and iuGC group emerges (Figure 10). Animals from 
both groups decreased their preference for a delayed, large, reward in a delay dependent way 
(Delay: Figure 10A: F(3, 72) = 10.63, p < 0.0001; Figure 10B: F(3, 72) = 23.07, p < 0.0001; Figure 
10C: F(3, 72) = 25.41, p < 0.0001; Figure 10D: F(3, 72) = 41.16, p < 0.0001). No effect of GC 
treatment on impulsive choice was found in the first 5 sessions (Group:  Figure 10A: F(1, 72) = 
1.766, p = 0.1881; Group x Delay:  Figure 10A: F(3, 72) = 0.03458, p = 0.9913). From sessions 6 
to 21, the performance of both groups is different. iuGC animals present increased lever presses 
in the large reward lever, in the no-delay condition (first block of trials) when compared to CONT 
animals (Group:  Figure 10B: F(1, 72) = 5.082, p = 0.0272; Figure 10C: F(1, 72) = 2.711, p = 0.1040; 
Figure 10D: F(1, 72) = 9.683, p = 0.0027).Further post hoc analysis confirmed the initial difference 
shown between CONT and iuGC animals, when no delay was present (Figure 10B: Bonferroni 
corrected t-test: t = 2.917, p < 0.05; Figure 10D: Bonferroni corrected t-test: t = 4.309, p < 
0.001). Despite initial differences, iuGC animals present a steeper discounting curve when 
compared to CONT animals, suggesting decreased delay gratification. 
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Figure 10. Performance in the delay discounting task of control and iuGC animals. (A) Choice percentage of the large reward 
across delays for CONT and iuGC animals, for the first 5 sessions. No differences found between groups. (B) Choice percentage 
of the large reward across delays in sessions 6-10, where, for the first block of trials (no delay block) iuGC animals had increased 
preference for the large reward, when compared to CONT animals. (C) Sessions 11-15 revealed no differences between groups 
in the percentage of preference for the large reinforcer. (D) Choice percentage of the large reward across delays in sessions 16-
21. iuGC animals had increased preference for the large reinforcer in the first block of trials, when compared to CONT. Data is 
shown as means ± SEM. nCONT=10; niuGC=10. *p<0.05, ***p<0.001. 
 
In order to further dissect the DD paradigm and the results obtained, a version of the DD 
task with shorter delays was performed (delay times: 0s, 5s, 10s, 15s and 30s; Figure 11). 
Results from this delay discounting paradigm showed that, as seen in the previous test, both 
CONT and iuGC animals delay-dependently decreased their choice for a large, but delayed, 
reward (Delay: Figure 11A: F(4, 90) = 23.98, p < 0.0001; Figure 11B: F(4, 90) = 25.98, p < 0.0001; 
Figure 11C: F(4, 90) = 31.03, p < 0.0001; Figure 11D: F(4, 90) = 21.83, p < 0.0001; Figure 11E: F(4, 90) 
= 33.36, p < 0.0001). Until session 16 and beyond, no significant difference was found between 
both groups in the percentage of choice for the large delayed reward (Group:  Figure 11A: F(1, 90) = 
0.06812, p = 0.7947; Figure 11B: F(1, 90) = 0.3765, p = 0.5410; Figure 11C: F(4, 90) = 0.2071, p = 
0.6501; Group x Delay: Figure 11A: F(4, 90) = 1.196, p = 0.3183; Figure 11B: F(4, 90) = 1.551, p = 
0.1942; Figure 11C: F(4, 90) = 1.863, p = 0.1239), though there is a clear trend for iuGC animals to 
prefer the large reward lever in the no-delay block.  
With further training, iuGC animals displayed an increased preference for the lever 
associated with a larger reinforcer when compared to the CONT group, in the no-delay condition. 
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Both groups were different in a delay-dependent manner (Group: Figure 11D: F(1, 90) = 0.2178, p = 
0.6419; Figure 11E: F(1, 90) = 1.612, p = 0.2075; Group x Delay: Figure 11D: F(4, 90) = 3.494, p = 
0.0106; Figure 11E: F(4, 90) = 3.394, p = 0.0124). Additional post hoc analysis further supported 
the difference between both animal groups (Figure 11D: Bonferroni corrected t-test: t = 3.355, p 
< 0.01; Figure 11E: Bonferroni corrected t-test: t = 3.566, p < 0.01). Despite the shorter delays 
applied in this task, iuGC animals revealed a steeper discount for the large reward than CONT 
animals, immediately after introduction of a delay of 5 s, suggesting a disruption in this type of 
behavior. 
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Figure 11. Performance in the delay discounting task of control and iuGC animals, with shorter delay intervals. (A) Choice 
percentage of the large reward across delays for CONT and iuGC animals, for the first 5 sessions. No differences were found 
between groups. (B) Choice percentage of the large reward across delays in sessions 6-10, where, also, no differences were 
revealed between iuGC animals and CONT animals. (C) Sessions 11-15 revealed no differences between groups in the 
percentage of preference for the large reinforcer. (D) Choice percentage of the large reward across delays in sessions 16-20, 
here, iuGC animals had increased preference for the large reinforcer in the first block of trials, when compared to CONT. (E) 
Sessions 21-28 showed that iuGC animals had increase preference for the large reinforcer, when compared to CONT animals. 
Results are represented as means ± SEM. nCONT=10; niuGC=10. **p<0.01. 
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4.4. Neuronal activation upon exposure to a delay discounting task 
Several brain regions have been associated with the DD task, such as the OFC, mPFC 
and the amygdala (Cardinal, 2006). The expression of the immediate early gene c-fos was 
evaluated as an indicator of regional activation, after DD performance. Animals were subdivided 
in each group: part of the animals performed the task as described in the previous chapter 
(task+) and another sub-group did not perform the task, but were allowed to eat food pellets until 
they were satiated in the operant chamber (task-). Representative photomicrographs from OFC, 
mPFC and amygdala are displayed in Figures 12, 14 and 16, respectively. The densities of c-fos 
positive nuclei (positive cell counts/mm2) in all areas of interest in the four groups of animals are 
shown in Figures 13, 15 and 17. 
Expression of c-fos was detected throughout the areas of interest of CONT and iuGC 
animals at 60min following initiation of DD task/placement in operant chamber, after 28 days of 
training. Animals presented neuronal activation of the 4 sub-regions of OFC (Figures 12 and 13). 
In the lOFC, animals that performed the task had an increase in c-fos reactivity when compared 
to the non-performing animals (CONT task- x CONT task+: Mann-Whitney U = 0.000, p = 0.0159; 
iuGC task- x iuGC task+: Mann-Whitney U = 1.000, p =0.0190; Figure 13A). 
 
 
Figure 12. Neuronal activation upon delay discounting task performance in the orbitofrontal cortex. (A) Boundaries between 
different sub-regions of OFC traced over brain slices correspond to the outlined counting regions (Adapted from Paxinos and 
Watson, 2007). (B) Photomicrograph from a representative CONT animal that did not perform the DD task, showing part of the 
OFC sub-regions and the c-fos expression (dark points). (C) Photomicrograph from a representative CONT animal that performed 
the DD task, showing representative c-fos expression. Photomicrograph from a representative iuGC animal that did not perform 
the DD task (D) or that performed DD task (E). Note the greater number of c-fos positive units in the animals that performed the 
task. dlOFC - dorsolateral orbitofrontal cortex; lOFC - lateral orbitofrontal cortex; vOFC - ventral orbitofrontal cortex; mOFC - medial 
orbitofrontal cortex; regions coordinates: 4.20mm from bregma for all OFC sub-regions. Bar = 100 µm. 
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In the vOFC (Figure 13B), iuGC task+ animals displayed a greater c-fos positive cell 
density count than iuGC task- animals (Mann-Whitney U = 0.000, p = 0.0238), whereas CONT 
task- and CONT task+ groups presented no statistically significant differences (Mann-Whitney U = 
2.000, p = 0.1429). 
On the contrary, statistical analysis of neuronal activation in the dlOFC revealed an 
increase in cell density of c-fos positive cells in the CONT task+ group, when compared to CONT 
task- animals (Mann-Whitney U = 1.000, p = 0.0317) and no differences between iuGC task- and 
iuGC task+ groups (Mann-Whitney U = 5.000, p = 0.2857), as displayed in Figure 11C. However, 
there is a tendency for an enhanced activation of the dlOFC area in the iuGC task- group than in 
the CONT task- group (Mann-Whitney U = 1.000, p = 0.0571; Figure 13C).  
Regarding the mOFC (Figure 13D), again, iuGC task+ animals showed a greater density 
in the c-fos positive cell population count than iuGC task- animals (Mann-Whitney U = 0.000, p = 
0.0238) and no differences were revealed between both CONT groups (Mann-Whitney U = 4.000, 
p = 0.2619). 
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Figure 13. Density of c-fos positive cells counted in OFC sub-regions, upon delay discounting task. (A) Both CONT and iuGC 
task+ animals had an increase in the c-fos positive cell density in the lOFC, when compared to CONT and iuGC task- animals. (B) 
In the vOFC, only iuGC task+ animals showed a significant increase in the density of c-fos positive cells. (C) CONT task+ animals 
show an increase in neuronal activation in the dlOFC. (D) In the mOFC, only iuGC task+ animals show a significant increase in 
neuronal activation. Data is shown as means ± SEM. nCONT task -=4; nCONT task +=6; niuGC task -=4; niuGC task +=6. *p<0.05. dlOFC - dorsolateral 
orbitofrontal cortex; lOFC - lateral orbitofrontal cortex; vOFC - ventral orbitofrontal cortex; mOFC - medial orbitofrontal cortex. 
CONT/iuGC task- represents animals that did not perform delay discounting task; CONT/iuGC task+ represents animals that did 
perform delay discounting task. 
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Neuronal activation in mPFC sub-regions (ACC, PLC and ILC) was also examined 
(Figures 14 and 15). The ACC sub-region showed greater c-fos positive cell density in the iuGC 
task+ group, when compared to iuGC task+ animals (Mann-Whitney U = 0.000, p = 0.0286; 
Figure 15A). This difference was not noted in the CONT sub-groups (Mann-Whitney U = 3.500, p 
= 0.1383; Figure 15A). Also, a decrease in cell density was noted in the iuGC task- group, 
comparing to CONT task- animals (Mann-Whitney U = 0.000, p = 0.0294; Figure 15A). 
Regarding the results from the PLC (Figure 15B), animals in the CONT task+ group had 
an increase in c-fos positive cell density, when compared to the CONT task- group (Mann-Whitney 
U = 0.500, p = 0.0262), whereas both iuGC task- and iuGC task+ groups showed no differences 
(Mann-Whitney U = 5.000, p = 0.3810). 
 
Figure 14. Neuronal activation upon delay discounting task performance in the medial prefrontal cortex. (A) Boundaries 
between different sub-regions of mPFC traced over brain slices correspond to the outlined counting regions (Adapted from 
Paxinos and Watson, 2007). (B) Photomicrograph from a representative CONT animal that did not perform the DD task, showing 
part of the mPFC sub-regions and the c-fos expression (dark points). (C) Photomicrograph from a representative CONT animal 
that performed the DD task, showing representative c-fos expression. Photomicrograph from a representative iuGC animal that did 
not perform the DD task (D) or that performed DD task (E). Note the greater number of c-fos positive units in the animals that 
performed the task. ACC - anterior cingulate cortex; PLC - prelimbic cortex; ILC - infralimbic cortex; regions coordinates: 3.24mm 
from bregma for all mPFC sub-regions. Bar = 100 µm. 
 
As in the previous sub-region, in the ILC, the CONT task+ group had an increase in c-fos 
positive cell density, when compared to the CONT task- group, (Mann-Whitney U = 0.000, p = 
0.0195; Figure 15C), whereas this was not observed with iuGC animals (Mann-Whitney U = 
7.000, p = 0.3524; Figure 15C).  
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 Figure 15. Density of c-fos positive cells in mPFC sub-regions, 60min after delay discounting task. (A) iuGC task+ animals had 
an increase in the c-fos positive cell density in the ACC and CONT task- animals show greater cell density counts that iuGC task- 
animals. (B) In the PLC, only CONT task+ animals show a significant increase in the density of c-fos positive cells. (C) CONT 
task+ animals show an increase in neuronal activation in the ILC. Data is shown as means ± SEM. nCONT task -=4; nCONT task +=6; niuGC task -=4; 
niuGC task +=6. *p<0.05. ACC - anterior cingulate cortex; PLC - prelimbic cortex; ILC - infralimbic cortex. CONT/iuGC task- represents 
animals that did not perform delay discounting task; CONT/iuGC task+ represents animals that did perform delay discounting 
task. 
 
Then, the two sub-regions of the amygdala (BLA and CeA) were evaluated (Figures 16 
and 17). Density of c-fos positive cells examination was different between CONT task- and CONT 
task + groups in the BLA (Mann-Whitney U = 0.000, p = 0.0358; Figure 17A). Similarly, iuGC 
task+ animals presented an increase in neuronal activation, comparing to iuGC task- animals 
(Mann-Whitney U = 1.000, p = 0.0247; Figure 17A). Also, a higher neuronal activation in this 
sub-region was noted in the iuGC task- group, when compared to the CONT task- group (Mann-
Whitney U = 0.000, p = 0.0498; Figure 17A). 
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Figure 16. Neuronal activation in the amygdala, coming after delay discounting task performance. (A) Boundaries between 
different sub-regions of the amygdala traced over brain slices correspond to the outlined counting regions (Adapted from Paxinos 
and Watson, 2007). (B) Photomicrograph from a representative CONT animal that did not perform the DD task, showing part of 
the amygdala sub-regions and the c-fos expression (dark points). (C) Photomicrograph from a representative CONT animal that 
performed the DD task, showing representative c-fos expression. Photomicrograph from a representative iuGC animal that did not 
perform the DD task (D) or that performed DD task (E). Note the greater number of c-fos positive units in the animals that 
performed the task. BLA – basolateral nucleus of the amygdala; CeA – central nucleus of the amygdala; regions coordinates:       
-2.28mm from bregma for the two amygdala sub-regions. Bar = 100 µm. 
 
Concerning the density of c-fos positive cells in the CeA, both CONT task+ and iuGC 
task+ display an increase, when compared to CONT task- and iuGC task- animals, respectively 
(CONT task- x CONT task+: Mann-Whitney U = 0.000, p = 0.0358; iuGC task- x iuGC task+: 
Mann-Whitney U = 0.000, p = 0.0139; Figure 17B), suggesting a similar activation between both 
groups.
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Figure 17. Density of c-fos positive cells counted in amygdala sub-regions, coming after delay discounting task. (A) iuGC task+ 
and CONT task+ animals had an increase in the c-fos positive cell density in the BLA and iuGC task- animals show greater cell 
density counts that CONT task- animals. (B) In the CeA, CONT task+ and iuGC task+ animals show a significant increase in the 
density of c-fos positive cells. Data is shown as means ± SEM. nCONT task -=4; nCONT task +=6; niuGC task -=4; niuGC task +=6. *p<0.05. BLA - basolateral 
amygdala; CeA - central amygdala. CONT/iuGC task- represents animals that did not perform delay discounting task; CONT/iuGC 
task+ represents animals that did perform delay discounting task. 
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5. General Discussion 
Impact of stress in early development 
During prenatal period, the fetus is protected from the effects of elevated GCs due to the 
action of the enzyme 11 -β-HSD-2, which is  highly  expressed  in  the  placenta  and  forms  a  
potent  barrier to  maternal  GCs (Seckl, 2004). However, a small quantity of endogenous GCs is 
able to cross the barrier and reach the fetus (Brown et al., 1996). This ‘leakage’ is particularly 
important since GCs are responsible for neuronal maturation, remodeling of axons and dendrites, 
as well as cell survival (Meyer, 1983; Meaney et al, 1996; McEwen, 2005; Cerqueira et al., 
2005; Dias-Ferreira et al., 2009). The balance in the production of GCs allows normal brain 
development, so prolonged exposure to stress/GCs can alter the neuronal patterns/circuitry of 
the developing brain. Indeed, studies have shown that offspring of mothers that received DEX 
treatment during the prenatal period, developed emotional and social problems (Trautman et al. 
1995). Also, derived from this hormone treatment, the offspring presented low birth weight, 
altered cardiovascular, endocrine and metabolic functions (French et al., 1999). Nonetheless, the 
beneficial effects of prenatal GCs are undeniable and these hormones are widely used in cases of 
risk of preterm delivery, to promote fetal lung maturation.  
Our group showed permanent deleterious effects of prenatal exposure to stress/GCs in 
the periphery and the brain (Oliveira et al., 2006; Leão et al., 2007; Rodrigues et al., 2011; 
Roque et al., 2011; Oliveira et al., 2012). This animal model of prenatal exposure to DEX showed 
an impairment of the HPA axis response; behavioral studies demonstrated that these animals 
developed an anxious-like phenotype and a depressive-like behavior. Furthermore, studies 
revealed that the mesolimbic dopaminergic system is a target of prenatal GCs action (Leão et al., 
2007; Rodrigues et al., 2011), since the VTA, which projects to several areas including the NAcc 
and PFC, displays a decrease in dopaminergic fibers (Leão et al., 2007). The alterations seen in 
the VTA and the hypodopaminergic state developed in the NAcc (Leão et al., 2007; Rodrigues et 
al., 2011) were associated with an increase in the vulnerability towards drug-seeking behavior in 
the offspring of DEX-treated dams (Rodrigues et al., 2011). These results are in accordance with 
those showing that dopamine (DA) is crucial for the motivating actions to achieve certain goals, 
eventually developing drug-seeking behavior (Robinson and Berridge, 2003; Berridge and 
Robinson, 1998; Palmiter, 2008). 
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Personality traits and addictive behavior 
Drug addiction is a complex behavioral disorder that can be instigated and perpetuated 
by stressful life events and predisposing personality characteristics, most notably impulsivity and 
novelty-seeking behavior. Those who become addicted may be more susceptible to the 
reinforcing effects of drugs or to the learned associations related to drug taking (Koob and Kreek, 
2007). Furthermore, vulnerability to addiction can be increased by genetic or physiological 
influences, enhancing the probability of an individual to shift from experimental to compulsive 
drug use (Nestler et al, 2001; Olmstead, 2006; Piazza and Le Moal, 1996). Together, these 
vulnerabilities may increase the risk of first-time use as well as maintenance and relapse of drug 
use. 
Increasing evidence has revealed a link between personality traits characterized by 
behavioral disinhibition, such as sensation/novelty-seeking and impulsivity, and the development 
of substance use disorders (Conway et al, 2003; Iacono et al, 2003; Kreek et al, 2005; Li, 2000; 
Limosin et al, 2003; Young et al, 2000). The association between these personality traits and 
substance abuse is not surprising, since the mesolimbic dopaminergic system, highly implicated 
in addictive disorders, may also underlie individual differences in trait impulsivity (Bergh et al, 
1997; Laine et al, 2001; Mann et al, 2001; Reist et al, 1996; Swann, 2003; Wade et al, 2000). 
Novelty-seeking behavior has been strongly associated with drug addiction (Koob and Le 
Moal, 2005; Wills et al, 1994; Woicik et al, 2009; Zuckerman and Neeb, 1979) and has been 
defined as the amount of activity displayed in a novel environment with animals that exhibit a 
high level of exploration, namely high responders in comparison with little exploration termed as 
low responders animals (Piazza et al, 1989). The high responder and low responder phenotypes 
represent differences in vulnerability to substance abuse and not only individual differences in 
locomotor activity, where high responder animals self-administer cocaine and amphetamine at 
higher rates (Piazza et al, 1989) and exhibit notable differences in their interaction with the 
environment, since high responder animals tend to seek novelty, variety, and emotional 
stimulation (Dellu et al, 1996; Kabbaj et al, 2000). In this manner, novelty-seeking behavior in 
the rat resembles sensation-seeking in humans (Dellu et al, 1996), a personality trait 
characterized for voluntary participation in activities involving personal risk and associated with 
substance abuse and alcoholism (Zuckerman and Neeb, 1979). Several paradigms may be used 
to the novelty-seeking condition, such as novelty-induced locomotor reactivity, Novelty Place 
Preference (NPP) and Novel Object Recognition (NOR) tests (Dellu et al, 1996; Blanchard et al, 
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2009; Molander et al, 2011). Regarding the locomotor reactivity in a novel environment, iuGC 
animals did not differ from their age-matched CONT animals, apart from the first 10 min of 
analysis and the higher percentage of time spent in the central area of the arena that further 
supported results from Oliveira et al. (2006).  
Differences in novelty responsiveness determine the degree of success in differentiating 
novel and old objects in an open arena, such that more reactive animals are less likely to 
recognize objects/places because of the training-induced emotional arousal. Based on the 
spontaneous and natural tendency of animals to explore novelty, we performed the NPP test, 
where iuGC animals did not explored the novel environment more than the familiar one, since the 
amount of time spent in each place was almost the same, which reveals a decrease in novelty 
preference and/or possibly, indicate some sort of memory impairment or unequal memory 
processing. Concerning the NOR test, iuGC animals presented an increase in the preference to a 
novel object as opposed to a familiar one, when the delay between test phases was 1 h. 
However, as this delay increased (24 h between phases), the offspring of DEX-treated dams did 
not distinguish the familiar and novel object, as opposed their age-matched CONT animals, 
further suggesting long-term memory impairment. The NOR paradigm is actually a model of 
spontaneous-episodic memory and not spontaneous-spatial memory (Ennaceur and Delacour, 
1988; Ennaceur et al, 1989). The task requires animals to remember previously encountered 
objects after a delay-dependent decline in memory retention, making this test sensitive to 
cognition-impairing (Ennaceur and Meliani, 1992; Puma et al, 1998; Woolley et al, 2003) and 
cognition-enhancing (Ennaceur et al, 1989; Puma et al, 1998) situations, also allowing 
pharmacological manipulations, if needed. Therefore it is important to note that this paradigm 
shows validity in the assessment of attention and memory, alongside novelty preference (Ballaz 
et al, 2007; Molander et al, 2010).  
Different endophenotypes have been associated with a predisposition to different stages 
of the addiction process, such as the high responder phenotype, predisposing to drug use, or 
others, including the high impulsive and high novelty preference phenotypes, facilitating the shift 
to compulsive drug intake and addiction (Belin et al, 2010). It is important to refer the 
dissociation between novelty preference and novelty-induced locomotor activity, since either 
pharmacological (Bardo et al, 1990) or molecular (Adriani et al, 2009) manipulations of novelty 
preference have been shown not to impact reactivity to a novel environment. Although novelty 
preference and locomotor reactivity to novelty are both blocked by microinfusions of 
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dopaminergic antagonists into the NAcc in rats (Bardo et al, 1989; Hooks and Kalivas, 1995), 
these behavioral tests are underlined by dissociable neurobiological mechanisms, including an 
important role of dopamine receptor 1 (D1) in the expression of novelty preference (Bardo et al., 
1993). Several studies revealed important implications for the neurobiology of the 
endophenotypes underlying the risk for drug addiction. Novelty-seeking high responder animals 
had increases in the DA release in the NAcc (Hooks et al, 1992; Flagel et al, 2010), a prolonged 
corticosterone response to mild novelty stress (Dellu et al, 1996) and lower levels of dopamine 
receptor 2 (D2) mRNA, also in the NAcc (Hooks et al, 1994). The high impulsive phenotype 
showed a reduction in dopamine receptors 2 and 3 (D2/3) in the ventral striatum, with no major 
differences in DA, when compared with the low impulsive phenotype (Dalley et al, 2007; 
Diergaarde et al, 2008). Thus, these studies suggest that impulsivity and novelty-seeking have 
distinct behavior outcomes and may also be associated with different adaptations within the 
mesolimbic dopaminenergic system (Molander et al, 2011). 
Impulsivity is characterized by several distinct features including delay aversion, impaired 
ability to consider consequences of an action, and behavioral disinhibition (Evenden, 1999). 
Across the lifespan, individuals may vary their degree of impulsivity and high levels of impulsivity 
can make an individual more susceptible to several psychiatric disorders, such as drug addiction 
(Olmstead, 2006), which can directly related with impulsive action and choice. Impulsive action 
reflects the inhibition of the capacity to withhold a response and impulsive choice refers to delay 
aversion or the inability to delay gratification. One can separate these types of impulsivity and 
they can be mutually exclusive (Winstanley et al, 2006). High baseline levels of either impulsive 
action or choice increase the risk of initiating, maintaining and relapsing to drug use in humans 
and animals (Perry and Carroll, 2008; Perry et al, 2005).  Different human studies showed that 
cocaine or heroin abusers prefer smaller, immediate rewards over larger but delayed rewards 
(both drug and non-drug) and displayed impaired inhibition on tasks measuring impulsive action 
(Fillmore and Rush, 2002; Kirby and Petry, 2004; Li et al, 2006).  In animal studies, high 
impulsive rats display greater drug-seeking behavior than low impulsive animals, suggesting that 
impulsivity influences drug taking behavior (Belin et al, 2008). Furthermore, impulsivity predicts 
the acquisition, escalation, and reinstatement of cocaine taking-behavior in that (Dalley et al, 
2007; Perry et al, 2005; Perry et al, 2008), where high impulsive animals displayed greater drug-
taking behavior in comparison to low impulsive rats. Thus, impulsivity appears to be a reliable 
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endophenotype for stimulant abuse in rodents, consistent with recent findings in human drug 
abusers (Ersche et al, 2010).  
Impulsive action was assessed through 5-CSRTT, where animals were tested for the 
anticipatory responses. Additionally, we checked the accuracy and omissions performed, that 
allowed to assess the level of attention and motivation. In this behavioral test, iuGC animals did 
not present differences in impulsive action, since their response was quite similar to CONT 
animals, as well as their motivation and attention levels. Moreover, an impulsive choice paradigm 
was used, the delay discounting test, where animals were tested on their preference for a small 
immediate reward rather than a large, more beneficial, but delayed reward. Here, iuGC animals 
presented a higher preference for the large reward at the moment where no delays were present; 
however, once a delay was introduced, these animals decrease their preference instantly. 
Moreover, when a DD test was performed with shorter periods of delay, a similar response was 
observed, meaning that with an introduction of a delay, iuGC animals shifted their response to 
preferably choose the small immediate reward. Although evidence suggests an altered 
performance in the DD test, it is important to refer that CONT and iuGC animals revealed a 
difference at the starting point of the last sessions of the DD test, which may influence the 
outcome of the test and biased our conclusions. Is therefore crucial to make adjustments in the 
DD protocol in order to achieve at least 80% of choice for the large reinforcer. 
 It is also important to refer that many studies have looked at the pharmacological effects 
of addictive drugs on measures of impulsivity including response inhibition. Cocaine 
administration increases impulsive choice in rats (Paine et al, 2003), as does acute morphine 
administration (Kieres et al, 2004) and chronic methamphetamine has been shown to increase 
impulsive choice in rats (Richards et al, 1999). It is, however, important to mention that some 
results for a given drug have not always been consistent. For example, studies showed that 
alcohol reduced delay discounting in humans (Ortner et al, 2003), while others revealed no effect 
of alcohol on this measure (Richards et al, 1999), and several investigators have found impulsive 
choice to be induced by alcohol in rats (Evenden & Ryan, 1999; Tomie et al, 1998). These 
discrepancies may in some cases be because the drugs (or the state of addiction) do not have a 
unitary effect on discounting, but one which depends heavily on the situation and the particular 
choices involved. 
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Neural correlates underlying impulsive choice 
The neural system in delay discounting performance is a complex and well balanced 
system comprising regions such as OFC, mPFC and amygdala. Considering the effects of GCs, 
these brain regions are target areas of their action and may be responsible for alterations in 
impulsive choice behavior. 
The OFC is a brain region that projects to the NAcc and is strongly implicated in the 
assessment of reward value, since studies revealed that lesions encompassing the OFC induced 
impulsive choice (Mobini et al, 2002). Also, dissociable effects of lesions to OFC sub-regions 
were found in the rat (Mar et al, 2011); mOFC-lesioned rats showed increased preference for the 
large delay reward, as opposed to the decrease seen in lOFC-lesioned animals. These findings 
were consistent with human imaging studies and suggest that functions of these sub-regions can 
contribute differently to the decision-making process. The increase in the neuronal activation of 
the vOFC and mOFC of iuGC animals may help explain the difference seen in the DD task, since 
CONT animals did not display any difference in the activation of the areas mentioned, apart from 
the dlOFC, though this remains to be confirmed. 
 
The mPFC that also projects to the NAcc is involved in reward-related learning (Balleine 
and Dickinson, 1998; Bechara et al, 1999; Richardson and Gratton, 1998; Tzschentke, 2000). 
ACC dysfunction may not be an important contributor to impulsive choice, despite the 
involvement of the ACC in reward-related learning (Bussey et al, 1997a; Bussey et al, 1997b; 
Cardinal et al, 2003; Parkinson et al, 2000), as studies that showed that lesions of the ACC had 
no effect in the choice of delayed reinforcements (Cardinal et al, 2001), but ACC seems to be 
involved in the selection of effortful options (Walton et al, 2003; Walton et al, 2002). However, 
ACC lesions can make rats motorically impulsive (leading to impulsive action) and to respond 
prematurely in situations where they are required to wait (Muir et al, 1996). Regarding animals 
prenatally exposed to GCs, the ACC showed a higher activation of this area upon performance of 
the DD task, though no differences were found in the 5-CSRTT. 
Considering the PLC and ILC sub-regions, iuGC animals did not display any differences in 
the c-fos positive cell density, comparing task – and task + animals. This reduced activation may 
be explained by studies performed where lesions in PLC and ILC appeared to lead to a loss of 
temporal discriminative stimulus control (Cardinal et al, 2003) and lesions of the mPFC induced 
a deficit in timing ability in rats (Dietrich and Allen, 1998), with impaired temporal discrimination 
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in the peak procedure, an operant task that assesses the ability to time a stimulus (Catania, 
1970; Roberts, 1981). 
 
The amygdala is interconnected with the NAcc and OFC. Animals prenatally exposed to 
GCs revealed a similar neuronal activation in both CeA and BLA. However, this area displayed a 
higher c-fos positive cell density before exposure to the DD test, in iuGC animals. Some studies 
comprising lesions in the BLA showed an increase in impulsive choice in a task involving choice 
between an immediate one-pellet reward and a delayed four-pellet reward (Winstanley et al, 
2004a; Winstanley et al, 2004b) and others demonstrated deficits when reward size is suddenly 
changed, upon amygdala inactivation (Salinas and McGaugh, 1996; Salinas et al, 1993), which 
has emotional significance and this brain area is well known to be involved in affective 
representation (Cardinal et al, 2002). As mentioned before, iuGC animals present an anxious-like 
behavior and, altogether, this could help explain the increased cell density seen in the BLA, in a 
basal situation.  
One should also mention the importance of the NAcc in this task. This area responds to 
anticipated rewards in humans, other primates, chicks, and rats (Bjork et al, 2004; Breiter et al, 
2001; Cromwell and Schultz, 2003; Izawa et al, 2005; Knutson et al, 2001; Martin and Ono, 
2000; Miyazaki et al, 1998; Schultz et al, 1992; Schultz et al, 2000) and is innervated by DA 
neurons that respond to errors in reward prediction in a manner appropriate for a teaching signal 
(Schultz, 1998; Schultz and Dickinson, 2000; Schultz et al, 1998) and interventional studies 
showed this area to be a key site for the motivational impact of impending rewards (Robbins and 
Everitt, 1996; Everitt et al, 1999; Parkinson et al, 2000; Cardinal et al, 2002; Robbins et al, 
2005). Considering results from Cardinal and colleagues (2001, 2003), lesion studies of the 
NAcc have shown to produce impulsive choice. 
It is of importance to mention complementary measures such as the assessment of DA 
levels, since studies from Wade et al. (2000) showed that D2 antagonists and mixed D1/D2 
antagonists induce impulsive choice. Impulsive choice or preference for immediate reinforcement 
is due to abnormally steep temporal discounting and it was suggested that this is due to a 
hypofunctional NAcc dopaminergic system (Johansen et al, 2002; Sagvolden et al, 1998). In this 
context, the observed NAcc hypodopaminergic state, together with D2 prominent changes in 
iuGC animals, may explain the changes observed in the DD protocol. 
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6. Conclusion 
Increasing evidence from the last few years has shown the permanent effects of prenatal 
stress that may ultimately lead to the development of several neuropsychiatric disorders in 
adulthood, such as depression, anxiety, or drug addiction. Herein, we showed that iuGC animals 
do not differ in their locomotor reactivity to a novel environment, nor to a novel object. However, 
a long-term memory impairment was revealed with the NOR test. Regarding the trait of 
impulsivity, these animals did not show alterations in impulsive action, but present differences in 
impulsive choice, though further tests are required in order to validate these observations. 
Moreover, iuGC animals present changes in the neuronal activation of OFC and mPFC sub-
regions. Altogether, our results seem to suggest that prenatal exposure to GCs program neuronal 
circuits involved in impulsivity which may may contribute for the enhanced drug-seeking behavior 
observed in these animals.  
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7. Future Perspectives 
Further complement of the analysis on traits associated with drug addiction would be 
achieved by measuring risky behavior. Thus, we believe that the evaluation of this trait using the 
Minho Gambling Test would be crucial. Furthermore, an additional impulsive task can be 
performed to better assess impulsive action. In the Go/No-Go task, or Stop-Signal task, a 
response must be intermittently withheld upon presentation of a cue, measuring impulsive action 
(Logan and Cowan, 1984; Logan, 1994).  
As explained in previous chapters, it would be crucial to perform the DD task using 
different parameters, in order to allow CONT animals to achieve better performance accuracy. 
 This would be accompanied with further determination of the neuronal activation 
patterns in the NAcc, also crucial in this type of behavior. Moreover, it would be interesting to 
control for the food reward component (naïve group), since we only had a group that was 
exposed to food pellets, and this may mask some of the c-fos activation results. 
It will be important to characterize the levels of DA in these areas, since this 
neurotransmitter plays a major role in impulsivity. Nonetheless, an interesting approach would be 
to evaluate the interactive nature of DA and serotonin and their influence in impulsive behavior, 
since there is a persistent paradox on DA-releasing stimulant medications and their improvement 
in symptoms of ADHD, while at the same time drugs that increase DA transmission (agonists or 
levodopa) appear to increase impulsivity, i.e., in the case of medication-induced side effects in 
Parkinson’s Disease (Dalley and Roiser, 2012). Moreover, a possible control and maintenance of 
future developments of addictive behavior may be achieved in individuals already vulnerable. 
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